Ocera Therapeutics, Inc.
DelistedCIK 1274644fmd_05DG06PX36YCDZ9XKZBGMQ7JNQManufacturing · Pharmaceutical PreparationsTemplate: Standard
Coverage: Jan 01, 2009 to Sep 30, 2017, 31 periods
Latest annual · FY2016
Millions- Total revenues
- 1
- Operating income
- (19)
- Net income
- (27)
- Free cash flow
- (22)
Latest quarter · Q3 FY2017
Millions- Net income
- (6)
Key stats
Open AnalysisCompound annual growth
- Revenue, 3 yearsFY2013 to FY2016
- +92.8%
- Revenue, 5 yearsFY2011 to FY2016
- -43.1%
- Net income, 5 yearsFY2011 to FY2016
- n/m
Ocera Therapeutics, Inc. financials: quick answers
Annual figures as filed with the SEC. Each number links to the filing it came from and to its proof.
| Metric | FY2016 | FY2015 | Change | Source |
|---|---|---|---|---|
| Revenue | $609,000 | $133,000 | +357.9% | 10-K 2017-03-14 · proof |
| Net income | -$26.9 million | -$26.5 million | 10-K 2017-03-14 · proof | |
| Cash from operating activities | -$22.1 million | -$20.6 million | 10-K 2017-03-14 · proof | |
| Free cash flow | -$22.1 million | -$20.7 million | 10-K 2017-03-14 · proof | |
| Total assets | $29.6 million | $44.7 million | -33.7% | 10-K 2017-03-14 · proof |
| Total liabilities | $13.9 million | $13.3 million | +4.2% | 10-K 2017-03-14 · proof |
| Cash and cash equivalents | $24.6 million | $35.9 million | -31.5% | 10-K 2017-03-14 · proof |
- What was Ocera Therapeutics, Inc.'s revenue in fiscal 2016?
- Ocera Therapeutics, Inc. reported revenue of $609,000 for fiscal 2016 (the year ended Dec 31, 2016), against $133,000 the year before (+357.9%). Source: the 10-K filed with the SEC on Mar 14, 2017. SEC
- What was Ocera Therapeutics, Inc.'s net income in fiscal 2016?
- Ocera Therapeutics, Inc. reported net income of -$26.9 million for fiscal 2016 (the year ended Dec 31, 2016), against -$26.5 million the year before. Source: the 10-K filed with the SEC on Mar 14, 2017. SEC
- What was Ocera Therapeutics, Inc.'s cash from operating activities in fiscal 2016?
- Ocera Therapeutics, Inc. reported cash from operating activities of -$22.1 million for fiscal 2016 (the year ended Dec 31, 2016), against -$20.6 million the year before. Source: the 10-K filed with the SEC on Mar 14, 2017. SEC
- What was Ocera Therapeutics, Inc.'s free cash flow in fiscal 2016?
- Ocera Therapeutics, Inc. reported free cash flow of -$22.1 million for fiscal 2016 (the year ended Dec 31, 2016), against -$20.7 million the year before. Source: the 10-K filed with the SEC on Mar 14, 2017. SEC
- What are Ocera Therapeutics, Inc.'s total assets?
- As of Dec 31, 2016, Ocera Therapeutics, Inc. reported total assets of $29.6 million, against $44.7 million a year earlier (-33.7%). Source: the 10-K filed with the SEC on Mar 14, 2017. SEC
- What are Ocera Therapeutics, Inc.'s total liabilities?
- As of Dec 31, 2016, Ocera Therapeutics, Inc. reported total liabilities of $13.9 million, against $13.3 million a year earlier (+4.2%). Source: the 10-K filed with the SEC on Mar 14, 2017. SEC
- What are Ocera Therapeutics, Inc.'s cash and cash equivalents?
- As of Dec 31, 2016, Ocera Therapeutics, Inc. reported cash and cash equivalents of $24.6 million, against $35.9 million a year earlier (-31.5%). Source: the 10-K filed with the SEC on Mar 14, 2017. SEC
Read from the FinancialMD API on Nov 14, 2026. Values change only when a new filing is made; see the Financials tab for every period and as-of replay.
The same numbers for an agent, with proof on every value:
curl "https://api.financial.md/v1/company/financials/income_statement/standardized?company=cik:1274644&period_type=annual&limit=5"Information only, not investment advice.